研究業績オープンアクセスジャーナルはPDFをダウンロード可能です。

2026年

原著

  • 1.Two-year treatment outcomes in neovascular age-related macular degeneration with type 3 macular neovascularization Fukuda Y, Shiose S, Notomi S, Maehara Y, Yuge K, Kiyohara K, Yasaka Y, Mori K, Fujiwara K, Kano K, Ishikawa K, Murakami Y, Sonoda KH; Eye. 2026/05/22 [Epub ahead of print]
  • 2.Intratarsal Keratinous Cyst Misdiagnosed as a Chalazion Complicated by an Intralesional Triamcinolone Injection: A Case Report Ken-Ichi Takaki, Tanabe M, Yoshikawa H, Sonoda KH; Cureus 18:10.7759/cureus.109075, 2026/05/18
  • 3.RPE With ROCK-Mediated Epithelial-Mesenchymal Transition as a Key Contributor of Subretinal Fibrosis in AMD Wada I, Ishikawa K, Yamaguchi M, Shimokawa S, Ji Rui, Mori K, Kaizu Y, Arima M, Notomi S, Murakami Y, Inagaki S, Kohro Y, Tsuda M, Shibata K, Terao R, Terabayashi T, Ishizaki T, Yoshida S, Ishibashi T, Ishida S, Rajendra S Apte, Sonoda KH, Nakao S; Invest Ophthalmol Vis Sci. 67(5):33, 2026/05/14
  • 4.Diagnostic utility of bony nasolacrimal duct area on computed tomography for differentiating malignant lacrimal tumors Nagata J, Tanabe M, Seki E, Koide R, Takaki K, Yamana K, Akiyama M, Yoshikawa H, Sonoda KH; Graefes Arch Clin Exp Ophthalmol. 2026/05/09 [Epub ahead of print]
  • 5.A hierarchical Rorc(γt) cis-regulatory cascade orchestrates differentiation of RORγt⁺ innate immune cells Fukui T, Watanabe M, Kobayashi R, Yamada T, Nakano K, Tanaka K, Harada A, Okumura T, Sonoda KH, Ohkawa Y, Sumiya E, Shao R, Suyama M, Taniuchi I, Kojo S, Sawa S; Immunity 59(4):953-969, 2026/04/14
もっと見る

総説

  • 1.A statement from Japanese experts on the appropriate use of teprotumumab for active thyroid eye disease Uchida T, Uchida T, Yamauchi I, Mimura M, Kanamoto N, Akiyama M, Azumi A, Goseki T, Hamada K, Horie I, Inoue R, Isozaki O, Iwaku K, Kitaguchi Y, Kudo T, Matsuzawa K, Miyake I, Murakami T, Nishijima Y, Obata H, Sakai K, Tani J, Takahashi S, Takahashi Y, Watanabe A, Yamaoka H, Noh JY, Hiromatsu Y, Kozaki A, Watanabe N; Thyroid Science 3(2):100040, 2026/05/01
  • 2.眼で見つかる神経疾患 上田瑛美; あたらしい眼科 43:259, 2026/03/30
  • 3.抗VEGF 薬治療の現場から見えてくる実態(正確な診断に向けた工夫と見落としの防止策) 塩瀬聡美; 眼科 1:11-24, 2026/02/01
  • 4.甲状腺眼症 田邉美香; 臨牀と研究 103:50-54, 2026/01/20
  • 5.網膜色素変性と遺伝子治療 村上祐介; 臨牀と研究 1:34-39, 2026/01/01

著書

  • 1.眼球運動検査 塚本晶子; 眼科診療エクレール 10:88-92, 2026/05/01
  • 2.重瞼形成術切開法 田邉美香; 眼科グラフィック 15:125-129, 2026/04/10
  • 3.Ⅲ 眼窩腫瘍 6. 1)血管腫、血管奇形 田邉美香; 新篇 眼科プラクティス22 眼腫瘍!? 迷った時のガイダンス 1:142-147, 2026/04/03
  • 4.Ⅲ 眼窩腫瘍 6. 2) 神経鞘腫 田邉美香; 新篇 眼科プラクティス22 眼腫瘍!? 迷った時のガイダンス 1:148-152, 2026/04/03

一般口演・ポスター発表

  • 1.RIPK3-RHIM Activation in Müller Glia Drives Retinal Neuroinflammation and Degeneration in a Mouse Model of Retinitis Pigmentosa Tao Yan, Shimokawa S, Zhao Huanyu, Fukushima M, Hisai T, Fukuda K, Guannan W, Yiming P, Notomi S, Ishikawa K, Sonoda KH, Furukawa T, Paschalis EI, Vavvas DG, Murakami Y; ARVO2026, Denver, USA, 2026/05/06
  • 2.Inflammatory Markers and Disease Progression in Moderate-Stage Retinitis Pigmentosa: Longitudinal Analysis from the RP-PRIMARY Study  Shimokawa S, Fukuda K, Hisai T, Fukushima M, Fujiwara K, Koyanagi Y, Notomi S, Ishikawa K, Tsukamoto S, Hierata A, Takada A, Miyahara F, Nakajima an, Kobayakawa Y, Mawatari T, Ishizu M, Sotoyana N, Kaida T, Miyata K, Ikeda Y, Sonoda KH, Murakami Y; ARVO2026, Denver, 2026/05/05
  • 3.Long-Term Outcomes of Lentivirus-Based Neuroprotective Gene Therapy for Retinitis Pigmentosa: A Phase I/IIa Investigator-Initiated Clinical Trial of DVC1-0401 Murakami Y, Hisai T, Mawatari G, Kohno RI, Sugita N, Shimokawa S, Fukushima M, Okita A, Funatsu J, Nakatake S, Fujiwara K, Ishizu M, Yoshida N, Kobayakawa Y, Sonoda KH, Ikeda Y; ARVO2026, Denver, USA, 2026/05/05
  • 4.Sensitive Visual Function Parameters for Detecting Disease Progression in Moderate-Stage Retinitis Pigmentosa: Data from the RP PRIMARY Registry Kawamura A, Hisai T, Shimokawa S, Fukuda K, Fukushima M, Fujiwara K, Ishizu M, Ikeda Y, Murakami Y; ARVO2026, Denver.USA, 2026/05/05
  • 5.Cytokine Profiling of Aqueous Humor in Herpesvirus-Associated Uveitis Kuramoto S, Yawata N, Tajima A, Tsutsui H, Nakamura R, Yamana S, Dyah Ayu Windy Asmara Putri, Uno K, Sonoda KH; The 130th Annual Meeting of the Japanese Ophthalmological Society, Fukuoka,Japan, 2026/04/12
もっと見る

特別・招待・教育講演など

  • 1.Clinical Benefits of Aflibercept 8mg and Future Perspective Sonoda KH; 2026 Busan Uveitis / AMD Summit conjoined with 
2026 Eylea Busan Power Forum Busan, Korea, 2026/04/17
  • 2.Single‐cell Analysis in Samples from Uveitis Patients  Sonoda KH; 2026 Busan Uveitis / AMD Summit conjoined with 
2026 Eylea Busan Power Forum Busan, Korea, 2026/04/17
  • 3.Efficacy and Safety of Vamikibart in UME: Results From MEERKAT/SANDCAT Trials Sonoda KH; 130th Annual Meeting of the Japanese Ophthalmological Society Fukuoka,Japan, 2026/04/11
  • 4.Vitreoretinal Surgeries using robotic endoscope holder  Sonoda KH; Joint New Technology Summit Hong Kong, 2026/02/07
  • 5.Robotics in Vitreoretinal Surgeries  Sonoda KH; CCOI Asia-Pacific Innovation Forum 2026 Hong Kong, 2026/02/04
もっと見る

シンポジウム・インストラクション・ワークショップ・ランチョンセミナーなど

  • 1.Retinal Imaging Research in Relation to the Brain Ueda E; 130th Annual Meeting of the Japanese Ophthalmological Society Fukuoka Fukuoka,Japan, 2026/04/10
  • 2.Future Directions in the Treatment of DRD: the position of Beovu Ishikawa K; FujiRETINA 2026 Morning Seminar Tokyo,Japan, 2026/03/29
  • 3.Utilization of POAG-PRS in Asian Populations Akiyama M; APAO 2026 Symposium Genome-Wide Association Studies (GWAS) and Polygenic Risk Scores (PRS) in Diverse Populations, Hong-Kong, China, 2026/02/07
  • 4.Timing of Vitrectomy After Traumatic Open Globe Injury and the Incidence of Proliferative Vitreoretinopathy Murakami Y; APAO 2026 Hong-Kong, China, 2026/02/06
  • 5.Gene-Specific and Gene-Agnostic Therapies for Inherited Retinal Diseases Murakami Y; The 16th International Collaborative Forum of Human Gene Therapy for Genetic Diseases Tokyo,Japan, 2026/01/23
もっと見る

その他

  • 1.Retinal and Vitreous Seeding as an Atypical Manifestation of Metastatic Renal Cell Carcinoma N Yawata, Yamana S, Matsui K, Ishikawa K, Sonoda KH; Fujiretina 2026 東京都, 2026/03/27
  • 2.眼瞼下垂診療の新たな視点 -鑑別疾患と点眼治療について- 田邉美香; 第9回九州眼形成・涙道研究会 宮崎県, 2026/05/29
  • 3.日常診療における眼腫瘍診断の要点 田邉美香; 岡山大学 Web セミナー Santen Okayama Ophthalmology Seminar 1890 to Future 岡山県, 2026/05/20
  • 4.網膜色素変性の治療に向けて 村上祐介; JRPS愛媛 医療講演会 医療講演 愛媛県, 2026/05/17
  • 5.眼瞼下垂による不具合と患者ニーズ 田邉美香; 眼瞼下垂診療の新たな選択肢ー知識と実践の最前線ー 東京都, 2026/05/14
もっと見る

関連ページ

  • スタッフ紹介
  • 九大眼科が主催する研究会
  • 教室員の学会・研究会での発表情報
  • 視能訓練士とは
  • 教室の沿革
  • 関連病院
  • 研究室紹介
  • 河村藤吉画伯の眼病図譜

関連リンク

  • 九州大学病院眼科初代教授 大西克知と狩野文庫